共 9 条
[1]
Oesterling J.E., Chan D.W., Epstein J.I., Kimball Jr. A.W., Bruzek D.J., Rock R.C., Brendler C.B., Walsh P.C., Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy, J Urol, 139, pp. 766-772, (1988)
[2]
Chu T.M., Murphy G.P., What's new in tumor markers for prostate cancer?, Urology, 27, pp. 487-491, (1986)
[3]
Partin A.W., Pound C.R., Clemens J.Q., Epstein J.I., Walsh P.C., Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years, Urol Clin North Am, 20, pp. 713-725, (1993)
[4]
Chodak G.W., Neumann J., Blix G., Sutton H., Farah R., Effect of external beam radiation therapy on serum prostate-specific antigen, Urology, 35, pp. 288-294, (1990)
[5]
Cadeddu J.A., Pearson J.D., Partin A.W., Epstein J.I., Carter H.B., Relationship between changes in prostate-specific antigen and prognosis of prostate cancer, Urology, 42, pp. 383-389, (1993)
[6]
Moul J.W., Prostate specific antigen only progression of prostate cancer, J Urol, 163, pp. 1632-1642, (2000)
[7]
Polascik T.J., Oesterling J.E., Partin A.W., Prostate specific antigen: A decade of discovery - What we have learned and where we are going, J Urol, 162, pp. 293-306, (1999)
[8]
Shipley W.U., Thames H.D., Sandler H.M., Hanks G.E., Zietman A.L., Perez C.A., Kuban D.A., Hancock S.L., Smith C.D., Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis, Jama, 281, pp. 1598-1604, (1999)
[9]
Partin A.W., Pearson J.D., Landis P.K., Carter H.B., Pound C.R., Clemens J.Q., Epstein J.I., Walsh P.C., Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases, Urology, 43, pp. 649-659, (1994)